Skip to main content
. 2024 Jan 23;21(1):e1004326. doi: 10.1371/journal.pmed.1004326

Table 3. Self-identified demographics of the Delphi panelists, per voting round.

Characteristic Round 1 (n = 58)
October 21–November 4, 2022
Round 2 (n = 54)
December 21, 2022–January 16, 2023
Round 3 (n = 51)
February 10–27, 2023
Gender, n (%)
Female
Male
Nonbinary
Prefer not to say
31 (53.4)
27 (46.6)
0
0
28 (51.9)
25 (46.3)
1 (1.9)
0
28 (54.9)
22 (43.1)
0
1 (2.0)
Geographic location of current primary residence and work, n (%)
Africa
Asia
Europe
North America
Oceania
South America
3 (5.2)
4 (6.9)
31 (53.4)
16 (27.6)
1 (1.7)
3 (5.2)
3 (5.6)
4 (7.4)
28 (51.9)
15 (27.8)
1 (1.9)
3 (5.6)
2 (3.9)
4 (7.8)
26 (51.0)
15 (29.4)
1 (2.0)
3 (5.9)
Background*, n (%)
Clinician
Journal editor
Patient partner
Policymaker
Publications professional
Researcher
Other
16 (27.6)
8 (13.8)
6 (10.3)
3 (5.2)
17 (29.3)
29 (50.0)
11 (19.0)
14 (25.9)
6 (11.1)
6 (11.1)
3 (5.6)
17 (31.5)
29 (53.7)
6 (11.1)
13 (25.5)
8 (15.7)
5 (9.8)
4 (7.8)
15 (29.4)
24 (47.1)
8 (15.7)

*Panelists could select more than one option.

In Rounds 2 and 3, this category was changed to Patient, Patient Partner, Family Member, or Carer.

Other occupation categories included:

In Round 1: Patient and Research Community: Pharmaceutical Physician; Research Funder; Academician (Professor); Guideline Developer; Medical Communications Services; Data Manager; Research in Medical Education; Healthcare Consultant; Patient Advocacy Leader; Physician; Health and Care Guideline Developer.

In Round 2: Data Manager; Medical Education Research and Clinician; Guideline Developer; Administrator; Professor.

In Round 3: Data Manager; Consensus Development Facilitator; Professor; Patient Organization; Guideline Developer.